| 查看: 851 | 回复: 24 | ||
| 【奖励】 本帖被评价22次,作者wanggch123增加金币 19 个 | ||
| 当前主题已经存档。 | ||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | ||
[资源]
【其他】分享 Advances in Medicinal Chemistry
|
||
|
Advances in Medicinal Chemistry Author: B.E. Maryanoff, A.B. Reitz Publisher: Elsevier Science (April 15, 1999) Media: Hardcover, 336 pages Price: $93.30 ISBN-10: 0762300647 ISBN-13: 9780762300648 Volume 4 of Advances in Medicinal Chemistry is comprised of six chapters on a wide range of topics in medicinal chemistry, including molecular modeling, structure-based drug design, organic synthesis, peptide conformational analysis, biological assessment, structure-activity correlation, and lead optimization. Chapter 1 presents an account about amino acid-based peptide mimetics corresponding to b-turn, loop, helical motifs in proteins as a probe of ligand-receptor and ligand-enzyme molecular interactions. Chapter 2 addresses new facets of the medicinal chemistry of the important anticancer drug Taxol® (paclitaxel). Chapter 3 relates an account of the search for new drugs for the treatment of malaria based on the natural product artemisinin. Chapter 4 applies computational chemistry to the evaluation of compound libraries for biological testing. Chapter 5 describes the construction of a 3-dimensional molecular model of the human thrombin receptor, the first protease-activated G-protein coupled receptor (PAR-1), as a means to explore the intermolecular contacts involved in agonist peptide recognition. Finally, Chapter 6 describes the research conducted at Merck on inhibitors of farnesyl transferase as a potential treatment for human cancers. 下载地址 http://www.namipan.com/d/0762300 ... 195f0c44e33f0bfea00 多多评价哦! |
» 猜你喜欢
求助冯连芳、张才亮的《聚合过程强化技术》
已经有1人回复
2026考博
已经有0人回复
药物学论文润色/翻译怎么收费?
已经有54人回复
浙江中医药大学张勇民院士2026年博士研究生招生
已经有3人回复
硫醚氧化
已经有2人回复
26博士申请-药物化学方向
已经有32人回复
求助cortellis数据库查询针对靶点ABCC6的药物和在研分子
已经有1人回复
章慧等编著的《配位化学:原理与应用》
已经有1人回复
求助!!!大佬救命!!!
已经有4人回复
酰胺缩合
已经有3人回复
8楼2009-09-25 14:18:48
6楼2009-09-25 12:16:36
9楼2009-09-25 14:19:22
10楼2009-09-25 16:03:04













回复此楼